294 related articles for article (PubMed ID: 21538175)
61. Anthocyanin-enriched bilberry and blackcurrant extracts modulate amyloid precursor protein processing and alleviate behavioral abnormalities in the APP/PS1 mouse model of Alzheimer's disease.
Vepsäläinen S; Koivisto H; Pekkarinen E; Mäkinen P; Dobson G; McDougall GJ; Stewart D; Haapasalo A; Karjalainen RO; Tanila H; Hiltunen M
J Nutr Biochem; 2013 Jan; 24(1):360-70. PubMed ID: 22995388
[TBL] [Abstract][Full Text] [Related]
62. Clinical phenotype and genetic associations in autosomal dominant familial Alzheimer's disease: a case series.
Ryan NS; Nicholas JM; Weston PSJ; Liang Y; Lashley T; Guerreiro R; Adamson G; Kenny J; Beck J; Chavez-Gutierrez L; de Strooper B; Revesz T; Holton J; Mead S; Rossor MN; Fox NC
Lancet Neurol; 2016 Dec; 15(13):1326-1335. PubMed ID: 27777022
[TBL] [Abstract][Full Text] [Related]
63. Non-cognitive behaviours in an APP/PS1 transgenic model of Alzheimer's disease.
Pugh PL; Richardson JC; Bate ST; Upton N; Sunter D
Behav Brain Res; 2007 Mar; 178(1):18-28. PubMed ID: 17229472
[TBL] [Abstract][Full Text] [Related]
64. Neuropathology of mice carrying mutant APP(swe) and/or PS1(M146L) transgenes: alterations in the p75(NTR) cholinergic basal forebrain septohippocampal pathway.
Jaffar S; Counts SE; Ma SY; Dadko E; Gordon MN; Morgan D; Mufson EJ
Exp Neurol; 2001 Aug; 170(2):227-43. PubMed ID: 11476589
[TBL] [Abstract][Full Text] [Related]
65. Large-scale gene expression changes in APP/PSEN1 and GFAP mutation models exhibit high congruence with Alzheimer's disease.
Gammie SC; Messing A; Hill MA; Kelm-Nelson CA; Hagemann TL
PLoS One; 2024; 19(1):e0291995. PubMed ID: 38236817
[TBL] [Abstract][Full Text] [Related]
66. Regional metabolic alteration of Alzheimer's disease in mouse brain expressing mutant human APP-PS1 by 1H HR-MAS.
Woo DC; Lee SH; Lee DW; Kim SY; Kim GY; Rhim HS; Choi CB; Kim HY; Lee CU; Choe BY
Behav Brain Res; 2010 Jul; 211(1):125-31. PubMed ID: 20307581
[TBL] [Abstract][Full Text] [Related]
67. Intravenous ascorbate improves spatial memory in middle-aged APP/PSEN1 and wild type mice.
Kennard JA; Harrison FE
Behav Brain Res; 2014 May; 264():34-42. PubMed ID: 24508240
[TBL] [Abstract][Full Text] [Related]
68. Geniposide Attenuates the Phosphorylation of Tau Protein in Cellular and Insulin-deficient APP/PS1 Transgenic Mouse Model of Alzheimer's Disease.
Zhang Y; Yin F; Liu J; Liu Z
Chem Biol Drug Des; 2016 Mar; 87(3):409-18. PubMed ID: 26475430
[TBL] [Abstract][Full Text] [Related]
69. Endogenous conversion of omega-6 into omega-3 fatty acids improves neuropathology in an animal model of Alzheimer's disease.
Lebbadi M; Julien C; Phivilay A; Tremblay C; Emond V; Kang JX; Calon F
J Alzheimers Dis; 2011; 27(4):853-69. PubMed ID: 21914946
[TBL] [Abstract][Full Text] [Related]
70. Multitarget Therapeutic Effect of Fasudil in APP/PS1transgenic Mice.
Yu JZ; Li YH; Liu CY; Wang Q; Gu QF; Wang HQ; Zhang GX; Xiao BG; Ma CG
CNS Neurol Disord Drug Targets; 2017; 16(2):199-209. PubMed ID: 27401064
[TBL] [Abstract][Full Text] [Related]
71. The effect of ageing on neurogenesis and oxidative stress in the APP(swe)/PS1(deltaE9) mouse model of Alzheimer's disease.
Hamilton A; Holscher C
Brain Res; 2012 Apr; 1449():83-93. PubMed ID: 22418058
[TBL] [Abstract][Full Text] [Related]
72. Long-Term Treatment with Liraglutide, a Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist, Has No Effect on β-Amyloid Plaque Load in Two Transgenic APP/PS1 Mouse Models of Alzheimer's Disease.
Hansen HH; Fabricius K; Barkholt P; Kongsbak-Wismann P; Schlumberger C; Jelsing J; Terwel D; Termont A; Pyke C; Knudsen LB; Vrang N
PLoS One; 2016; 11(7):e0158205. PubMed ID: 27421117
[TBL] [Abstract][Full Text] [Related]
73. T cell protein tyrosine phosphatase (TCPTP) deficiency in muscle does not alter insulin signalling and glucose homeostasis in mice.
Loh K; Merry TL; Galic S; Wu BJ; Watt MJ; Zhang S; Zhang ZY; Neel BG; Tiganis T
Diabetologia; 2012 Feb; 55(2):468-78. PubMed ID: 22124607
[TBL] [Abstract][Full Text] [Related]
74. The amyloid precursor protein (APP) family members are key players in S-adenosylmethionine formation by MAT2A and modify BACE1 and PSEN1 gene expression-relevance for Alzheimer's disease.
Schrötter A; Pfeiffer K; El Magraoui F; Platta HW; Erdmann R; Meyer HE; Egensperger R; Marcus K; Müller T
Mol Cell Proteomics; 2012 Nov; 11(11):1274-88. PubMed ID: 22879628
[TBL] [Abstract][Full Text] [Related]
75. Long-term treadmill exercise inhibits the progression of Alzheimer's disease-like neuropathology in the hippocampus of APP/PS1 transgenic mice.
Liu HL; Zhao G; Zhang H; Shi LD
Behav Brain Res; 2013 Nov; 256():261-72. PubMed ID: 23968591
[TBL] [Abstract][Full Text] [Related]
76. Improved glucose-stimulated insulin secretion by intra-islet inhibition of protein-tyrosine phosphatase 1B expression in rats fed a high-fat diet.
Lu B; Wu H; Gu P; Du H; Shao J; Wang J; Zou D
J Endocrinol Invest; 2012 Jan; 35(1):63-70. PubMed ID: 21646858
[TBL] [Abstract][Full Text] [Related]
77. Hyperphosphorylated tau and paired helical filament-like structures in the brains of mice carrying mutant amyloid precursor protein and mutant presenilin-1 transgenes.
Kurt MA; Davies DC; Kidd M; Duff K; Howlett DR
Neurobiol Dis; 2003 Oct; 14(1):89-97. PubMed ID: 13678670
[TBL] [Abstract][Full Text] [Related]
78. Amelioration of high fat diet-induced glucose intolerance by blockade of Smad4 in pancreatic beta-cells.
Li HY; Oh YS; Lee YJ; Lee EK; Jung HS; Jun HS
Exp Clin Endocrinol Diabetes; 2015 Apr; 123(4):221-6. PubMed ID: 25502579
[TBL] [Abstract][Full Text] [Related]
79. Genetic influences on atrophy patterns in familial Alzheimer's disease: a comparison of APP and PSEN1 mutations.
Scahill RI; Ridgway GR; Bartlett JW; Barnes J; Ryan NS; Mead S; Beck J; Clarkson MJ; Crutch SJ; Schott JM; Ourselin S; Warren JD; Hardy J; Rossor MN; Fox NC
J Alzheimers Dis; 2013; 35(1):199-212. PubMed ID: 23380992
[TBL] [Abstract][Full Text] [Related]
80. Adipocyte-specific protein tyrosine phosphatase 1B deletion increases lipogenesis, adipocyte cell size and is a minor regulator of glucose homeostasis.
Owen C; Czopek A; Agouni A; Grant L; Judson R; Lees EK; Mcilroy GD; Göransson O; Welch A; Bence KK; Kahn BB; Neel BG; Mody N; Delibegović M
PLoS One; 2012; 7(2):e32700. PubMed ID: 22389718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
